Abstract:Background. YiQi YangYin Decoction (YQ) is a modern Chinese formula composed by the guidance of traditional Chinese medicine theory, which consists of nine traditional Chinese medicines and is applied to treat type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver in clinic in China for more than a decade. This study aims to evaluate the antidiabetes and lipid-lowering effect of YQ and explore the possible mechanisms of this action. Methods. T2DM rat models were established and given YQ at three different doses for three weeks. Tissues, including pancreas islet and liver, and blood serum were collected. The levels of fasting blood glucose (FBG), fasting insulin (Fins), lipid index, such as total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL), and hepatic function index such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) in serum were measured. Pancreas islet damage and liver damage were observed by hematoxylin and eosin staining. The glycogen content and lipid accumulation in liver were determined by periodic acid-Schiff (PAS) staining and Oil Red O staining. The expression levels of insulin receptor substrate 2 (IRS-2), phosphatidylinositol 3 kinase-associated p85alpha (PI3K p85α), AKT, and Glucose Transporter 2 (Glut4) in pancreas islet and AMP-activated protein kinase alpha (AMPKα), sterol regulatory element-binding protein 1c (SREBP1c), acetyl-CoA carboxylase (ACC1), and peroxisome proliferator‐activated receptor-α (PPARα) in liver were determined by western blotting. The relative expressions of ACC1, fatty acid synthase (FAS), stearoyl-CoA desaturase 1 (SCD1), carnitine palmityl transferase-1 (CPT-1), and SREBP-1 mRNA were detected by qRT-PCR. Results. After administering YiQi for three weeks, the levels of fast blood glucose, fasting insulin, TC, TG, LDL, ALT, AST, and ALP were significantly decreased, while HDL significantly increased compared with the model group. YQ could obviously attenuate pancreatic damage and improve islet α- and ß-cell survival compared with the model group. Furthermore, YQ could attenuate hepatic damage caused by lipid accumulation, decrease the content of lipid, and increase the hepatic glycogen content, compared with the model group. In addition, YQ remarkably elevated the proteins expression of p-PI3K, p-AKT, and GLUT4 in pancreas islet and elevated the proteins expression of p-PI3K, p-AKT, GLUT4, p-AMPK, SREBP1, and PPARα and inhibited the expression of p-ACC1 in liver. Besides, YQ reduced the relative expression of ACC1, FAS, SERBP-1c, and SCD mRNA along with the decreased production of CPT-1 mRNA. Conclusions. YQ could attenuate type 2 diabetes mellitus by improving islet α- and ß-cells via IRS-2/AKT/GLUT4 pathway and nonalcoholic fatty liver by ameliorating lipid accumulation via AMPK/PPARα/SREBP1/ACC1 pathway.

Clinical Observation on 46 Cases of Type 2 Diabetes Mellitus Complicated with Fatty Liver Treated by Yiqi Yangyin and Huoxue Herbal Medicines

Study on clinical effect of Yiqi Yangyin and Huoxue Prescription imposed on fatty liver in type 2 diabetes mellitus

Study of Relation Between Insulin Resistance and Fatty Liver in Type 2 Diabetes and Clinical Effect of Yiqi Yangyin and Huoxue Prescription

Clinical observation of "DM120 Decoction" for type 2 diabetes mellitus: A report of 30 cases

Study on the Relations Between Abnormality of Insulin Resistance, Serum Leptin and Fatty Liver in Type 2 Diabetes Mellitus

Correlations between TCM syndrome type and insulin resistance index,adiponectin leptin ratio in patients with nonalcoholic fatty liver disease

Clinical observation on the effects of yiqi Huaju herb formula on type 2 diabetes subjects coupled with central obesity

Treating Type 2 Diabetes Mellitus Patients Complicated with Metabolic Syndrome by Benefiting Qi Dissolving Method

Effect of Qidi Xiaoke Prescription on C-peptide, Tumor Necrosis Factor-α, Interleukin-6, and Histopathological Changes of the Spleen in Rats with Type 2 Diabetes with Deficiency of Both Qi and Yin

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease

Chinese Herbal Medicine for Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Progress of Clinical Research on Prevention and Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver by Traditional Chinese Medicine

Clinical study of diabetes combined with non-alcoholic fatty liver disease with soothing liver for dredging collaterals formula

YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats

Clinical Observation of "qinggan Huayu Decoction" in Treating Hepatic Fibrosis Following Nonalcoholic Fatty Liver Diseases

Clinical Study on Treatment of Type 2 Diabetes from Aspects of Liver,spleen and Kidney

The Effect of Huayu Jiangzhuo Mixture on Lipid Metabolism in Type 2 Diabetes Mellitus with Improved Glycemic Control

Clinical Research of Modified Ling-Gui-zhu-gan Decoction Combined with Short-Term Very-Low-calorie-diet in Treatment of Hyperlipidemia Combined with Fatty Liver(splenic Hypofunction and Dampness Accumulation Type)

Effect of Huangqi Xiaoke decoction plus liraglutide on glucose and lipid metabolism and serum adipocytokines in patients with type 2 diabetes mellitus with substandard HbA1c after oral administration of various hypoglycemic drugs

Therapeutic Efficacy Evaluation by a Randomized Controlled Clinical Research on Traditional Chinese Medical Formulas,with Herb Modification According to Syndrome Differentiation,in the Treatment of 200 Type 2 Diabetic Patients

Research on the Relation between Type 2 Diabetes with Nonalcoholic Fatty Liver and Blood Lipid Disorders